Can-Fite BioPharma Investor Relations Material
Latest events
C-level Sitdown
Can-Fite BioPharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Can-Fite BioPharma Ltd
Access all reports
Can-Fite BioPharma Ltd is an Israel-based clinical-stage biopharmaceutical company focused on developing oral small molecule drugs for the treatment of cancer, liver, and inflammatory diseases. The company’s drug candidates target the A3 adenosine receptor, which is highly expressed in pathological cells. Its pipeline includes treatments for conditions such as liver cancer, psoriasis, and osteoarthritis. Can-Fite conducts clinical trials and collaborates with international research institutions. The company is headquartered in Petah Tikva, Israel, and its shares are listed on the NYSE American.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
CANF
Country
🇮🇱 Israel